{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:37:35Z","timestamp":1784389055338,"version":"3.55.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.pathol.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:59:01Z","timestamp":1614963541000},"page":"349-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["New developments in non-Hodgkin lymphoid malignancies"],"prefix":"10.1016","volume":"53","author":[{"given":"Karthik A.","family":"Ganapathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.01.002_bib1","series-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.pathol.2021.01.002_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2019.08.019","article-title":"As the world turns, evolving lymphoma classifications-past, present and future","volume":"95","author":"Swerdlow","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib3","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.pathol.2021.01.002_bib4","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib5","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2012-12-471698","article-title":"Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL","volume":"121","author":"Vardi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2015-02-585059","article-title":"Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification","volume":"126","author":"Strati","year":"2015","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2021.01.002_bib7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1002\/cyto.b.20533","article-title":"Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)","volume":"78","author":"Rawstron","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.pathol.2021.01.002_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2016.172","article-title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome","volume":"31","author":"Barrio","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia","volume":"360","author":"Landgren","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.01.002_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3324\/haematol.2011.042333","article-title":"Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis","volume":"96","author":"Gibson","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/blood-2013-07-515155","article-title":"Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?","volume":"123","author":"Xochelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib12","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","author":"Agathangelidis","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/jclinpath-2017-204364","article-title":"Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma\/chronic lymphocytic leukaemia","volume":"70","author":"Teixeira Mendes","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.13844","article-title":"Proliferation centres of chronic lymphocytic leukaemia\/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene","volume":"175","author":"Gibson","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/leu.2011.247","article-title":"Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays","volume":"26","author":"Ciccone","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\"accelerated\" chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gine","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib17","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib18","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter's transformation in chronic lymphocytic leukemia","author":"Klintman","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2559.2011.03897.x","article-title":"Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes","volume":"59","author":"Henopp","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2021.01.002_bib20","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3109\/10428194.2013.788177","article-title":"Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking","volume":"54","author":"Hirt","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.01.002_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404035","article-title":"Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals","volume":"20","author":"Roulland","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2017-08-737361","article-title":"Chromatin modifying gene mutations in follicular lymphoma","volume":"131","author":"Green","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2021.01.002_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2018-07-865428","article-title":"Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016","volume":"133","author":"Qu","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212813","article-title":"Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"14","author":"Gonzalez-Rincon","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.pathol.2021.01.002_bib27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A\u00a0distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.pathol.2021.01.002_bib31","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.01.002_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","article-title":"Primary follicular lymphoma of the testis in children and adolescents","volume":"34","author":"Lones","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib33","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib34","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-019-02704-8","article-title":"Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas","volume":"476","author":"Montes-Moreno","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.01.002_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.01.002_bib37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior","volume":"97","author":"Carvajal-Cuenca","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1(-) mantle cell lymphoma","volume":"133","author":"Martin-Garcia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ajcp\/aqy144","article-title":"IRTA1 and MNDA expression in marginal zone lymphoma: utility in differential diagnosis and implications for classification","volume":"151","author":"Wang","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAI.0000000000000738","article-title":"Myeloid cell nuclear differentiation antigen (MNDA) positivity in primary follicles: potential pitfall in the differential diagnosis with marginal zone lymphoma","volume":"28","author":"Manohar","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pathol.2021.01.002_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","article-title":"Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall","volume":"44","author":"Egan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib47","first-page":"470","article-title":"Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection","volume":"90","author":"Traverse-Glehen","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2017.1.371","article-title":"Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma","author":"Thieblemont","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.pathol.2021.01.002_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2021.01.002_bib50","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bjh.15502","article-title":"A\u00a0BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression","volume":"183","author":"Simonetti","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/ajh.25653","article-title":"Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Maitre","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib52","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia","volume":"27","author":"Jimenez","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib53","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib54","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41375-020-01102-3","article-title":"CXCR4 in Waldenstrom's macroglobulinema: chances and challenges","volume":"35","author":"Kaiser","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2021.01.002_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hon.2399","article-title":"The 2016 updated WHO classification of lymphoid neoplasias","volume":"35","author":"Quintanilla-Martinez","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib58","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib59","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1002\/cncr.31646","article-title":"Double hit and double expressors in lymphoma: Definition and treatment","volume":"124","author":"Riedell","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2021.01.002_bib60","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.01.002_bib61","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.01.002_bib62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jha2.93","article-title":"Genomic profiling of CD20 negative diffuse large B cell lymphoma identifies targetable mutations: A case report","volume":"1","author":"Maqbool","year":"2020","journal-title":"eJHaem"},{"key":"10.1016\/j.pathol.2021.01.002_bib63","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ajh.25112","article-title":"EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management","volume":"93","author":"Castillo","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib64","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.01.002_bib65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib66","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jclinpath-2019-206267","article-title":"Application of 2016 WHO classification in the diagnosis of paediatric high-grade MYC-negative mature B-cell lymphoma with Burkitt-like morphological features","volume":"73","author":"Zhang","year":"2020","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib69","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/bloodadvances.2020001551","article-title":"Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma","volume":"4","author":"Sermer","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.01.002_bib70","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000818","article-title":"Further exploration of the complexities of large B-cell lymphomas with MYC abnormalities and the importance of a blastoid morphology","volume":"41","author":"Moore","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11864-017-0483-z","article-title":"Clinical impact of the 2016 update to the WHO lymphoma classification","volume":"18","author":"Lynch","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib72","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3109\/10428194.2016.1143939","article-title":"Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges","volume":"57","author":"Moench","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2021.01.002_bib73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41379-018-0112-9","article-title":"High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma","volume":"32","author":"Ok","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib75","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000001186","article-title":"The spectrum of EBV-positive mucocutaneous ulcer: a study of 9 cases","volume":"43","author":"Prieto-Torres","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP workshop report-part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.humpath.2017.09.013","article-title":"A\u00a0distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer","volume":"69","author":"Ohata","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib79","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A\u00a0brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pathol.2021.01.002_bib81","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","article-title":"Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?","volume":"106","author":"Grogg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib82","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib83","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers","volume":"32","author":"Rodriguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib84","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib85","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib86","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/modpathol.2016.113","article-title":"Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-\/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic","volume":"29","author":"Alikhan","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib87","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib88","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A\u00a0targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2021.01.002_bib90","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.18632\/oncotarget.24592","article-title":"Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features","volume":"9","author":"Manso","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2021.01.002_bib91","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib92","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5376","article-title":"Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell","volume":"250","author":"Yao","year":"2020","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib95","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","article-title":"ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma","volume":"37","author":"Attygalle","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/17474086.2019.1583102","article-title":"New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination","volume":"12","author":"Ma","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib97","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib98","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib99","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib101","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib102","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib103","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib104","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\"Double-hit\" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2021.01.002_bib106","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib108","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib109","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib110","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib111","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41379-018-0134-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma","volume":"42","author":"Ferrufino-Schmidt","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pathol.2021.01.002_bib114","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.19.02778","article-title":"Best practices guideline for the pathologic diagnosis of breast implant-associated anaplastic large-cell lymphoma","volume":"38","author":"Jaffe","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.pathol.2021.01.002_bib116","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib117","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/blood.2020005372","article-title":"Chromosome 20 loss is characteristic for breast implant-associated anaplastic large cell lymphoma","volume":"136","author":"Los-de Vries","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib118","first-page":"360","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib119","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2021.01.002_bib120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib121","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00428-018-2352-y","article-title":"Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma","volume":"473","author":"Letourneau","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.01.002_bib122","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib123","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/his.13932","article-title":"Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management","volume":"75","author":"Jones","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2021.01.002_bib124","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression","volume":"35","author":"Chan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","article-title":"Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group","volume":"87","author":"Tse","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib126","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib127","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2017.145","article-title":"SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"31","author":"Mutzbauer","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.semdp.2019.08.001","article-title":"Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders","volume":"37","author":"Soderquist","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib129","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.01.002_bib130","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairismagi","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2021.01.002_bib131","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2021.01.002_bib132","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2021.01.002_bib133","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1182\/bloodadvances.2020001782","article-title":"Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"4","author":"Huang","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2021.01.002_bib134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","article-title":"Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update","volume":"35","author":"Matnani","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896918785985","article-title":"Disease progression in a patient with indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"27","author":"Perry","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib136","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/gast.1996.v111.pm8780585","article-title":"Primary gastrointestinal T-cell lymphoma resembling multiple lymphomatous polyposis","volume":"111","author":"Hirakawa","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2021.01.002_bib137","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.dld.2003.09.019","article-title":"Multiple lymphomatous polyposis of the colon originating from T-cells: a case report","volume":"36","author":"Isomoto","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pathol.2021.01.002_bib138","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","author":"Sharma","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib139","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2021.01.002_bib140","first-page":"32","article-title":"Epstein-Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis","volume":"37","author":"Montes-Mojarro","year":"2020","journal-title":"SDP"},{"key":"10.1016\/j.pathol.2021.01.002_bib141","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.10094","article-title":"Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease\/lymphoma: clinicopathologic, serologic, and molecular analysis","volume":"70","author":"Mitarnun","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib142","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2021.01.002_bib143","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib144","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib145","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2021.01.002_bib146","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/DAD.0000000000001737","article-title":"Atypical BCL6\/GATA3+ primary cutaneous acral CD8-positive T-cell lymphoma: a diagnostic challenge","volume":"43","author":"Prieto-Torres","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib147","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2021.01.002_bib148","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bjh.15572","article-title":"Primary cutaneous acral CD8(+) T-cell lymphomas relapse more frequently in younger patients","volume":"185","author":"Maubec","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2021.01.002_bib149","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/cup.13020","article-title":"Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: A long-standing case with an unexpected progression","volume":"44","author":"Alberti-Violetti","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/DAD.0000000000001490","article-title":"Adnexotropism as a histopathological clue for the diagnosis of primary cutaneous CD4+ small\/medium-sized T-cell lymphoproliferative disorder","volume":"42","author":"Perez Gonzalez","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pathol.2021.01.002_bib151","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2021.01.002_bib152","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/PAS.0000000000001470","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60 cases presenting with a single lesion: a multicenter study of the French Cutaneous Lymphoma Study Group","volume":"44","author":"Beltzung","year":"2020","journal-title":"Am J Surg Pathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:06:48Z","timestamp":1671516408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0031302521000441"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.01.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New developments in non-Hodgkin lymphoid malignancies","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}